AUB ScholarWorks

HbA1c diagnostic categories and β-cell function relative to insulin sensitivity in overweight-obese adolescents

Show simple item record

dc.contributor.author Sjaarda L.A.
dc.contributor.author Michaliszyn S.F.
dc.contributor.author Lee S.
dc.contributor.author Tfayli H.
dc.contributor.author Bacha F.
dc.contributor.author Farchoukh L.
dc.contributor.author Arslanian S.A.
dc.contributor.editor
dc.date Dec-2012
dc.date.accessioned 2017-10-05T16:01:17Z
dc.date.available 2017-10-05T16:01:17Z
dc.date.issued 2012
dc.identifier 10.2337/dc12-0747
dc.identifier.isbn
dc.identifier.issn 01495992
dc.identifier.uri http://hdl.handle.net/10938/19409
dc.description.abstract OBJECTIVE - The recommended HbA1c diagnostic categories remain controversial and their utility in doubt in pediatrics. We hypothesized that alterations in the pathophysiologic mechanisms of type 2 diabetes may be evident in the American Diabetes Association recommended at-risk-prediabetes category (HbA1c 5.7 to andlt;6.5percent). RESEARCH DESIGN AND METHODS - We compared in vivo hepatic and peripheral insulin sensitivity by [6,6-2H 2] glucose and a 3-h hyperinsulinemic-euglycemic clamp and β-cell function by a 2-h hyperglycemic clamp (∼225 mg-dL) in overweight-obese (BMI ≥85th percentile) adolescents with prediabetes (HbA1c 5.7 to andlt;6.5percent) (n = 160) to those with normal HbA 1c (andlt;5.7percent) (n = 44). β-Cell function was expressed relative to insulin sensitivity (i.e., the disposition index = insulin sensitivity X first-phase insulin). RESULTS - In the prediabetes versus normal HbA 1c category, fasting glucose, insulin, and oral glucose tolerance test (OGTT) area under the curve for glucose and insulin were significantly higher; hepatic and peripheral insulin sensitivity were lower; and β-cell function relative to insulin sensitivity was lower (366 ± 48 vs. 524 ± 25 mg-kg-min; P = 0.005). A total of 27percent of youth in the normal HbA1c category and 41percent in the prediabetes HbA1c category had dysglycemia (impaired fasting glucose and-or impaired glucose tolerance) by a 2-h OGTT. CONCLUSIONS - Overweight-obese adolescents with HbA1c in the at-risk-prediabetes category demonstrate impaired β-cell function relative to insulin sensitivity, a metabolic marker for heightened risk of type 2 diabetes. Thus, HbA1c may be a suitable screening tool in large-scale epidemiological observational and-or interventional studies examining the progression or reversal of type 2 diabetes risk. © 2012 by the American Diabetes Association.
dc.format.extent
dc.format.extent Pages: (2559-2563)
dc.language English
dc.publisher ALEXANDRIA
dc.relation.ispartof Publication Name: Diabetes Care; Publication Year: 2012; Volume: 35; no. 12; Pages: (2559-2563);
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title HbA1c diagnostic categories and β-cell function relative to insulin sensitivity in overweight-obese adolescents
dc.type Article
dc.contributor.affiliation Sjaarda, L.A., Division of Weight Management and Wellness, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, United States
dc.contributor.affiliation Michaliszyn, S.F., Division of Weight Management and Wellness, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, United States
dc.contributor.affiliation Lee, S., Division of Weight Management and Wellness, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, United States
dc.contributor.affiliation Tfayli, H., Department of Pediatrics and Adolescent Medicine, Pediatric Endocrinology, American University of Beirut, Beirut, Lebanon
dc.contributor.affiliation Bacha, F., Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States
dc.contributor.affiliation Farchoukh, L., Division of Weight Management and Wellness, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, United States
dc.contributor.affiliation Arslanian, S.A., Division of Weight Management and Wellness, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, United States, Division of Pediatric Endocrinology, Metabolism and Diabetes Mellitus, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, United States
dc.contributor.authorAddress Arslanian, S.A.; Division of Weight Management and Wellness, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, United States; email: silva.arslanian@chp.edu
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Pediatrics and Adolescent Medicine;
dc.contributor.authorDepartment Pediatrics and Adolescent Medicine
dc.contributor.authorDivision
dc.contributor.authorEmail silva.arslanian@chp.edu
dc.contributor.faculty Faculty of Medicine
dc.contributor.authorInitials Sjaarda, LA
dc.contributor.authorInitials Michaliszyn, SF
dc.contributor.authorInitials Lee, S
dc.contributor.authorInitials Tfayli, H
dc.contributor.authorInitials Bacha, F
dc.contributor.authorInitials Farchoukh, L
dc.contributor.authorInitials Arslanian, SA
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress Arslanian, SA (reprint author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Div Weight Management and Wellness, Pittsburgh, PA 15213 USA.
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Abdul-Ghani MA, 2007, DIABETES CARE, V30, P1544, DOI 10.2337-dc06-1331; American Diabetes Association, 2010, DIABETES CARE S1, V33, pS11, DOI DOI 10.2337-DC10-S011; Arslanian SA, 2005, HORM RES, V64, P16, DOI 10.1159-000089313; Arslanian SA, 2002, DIABETES, V51, P3014, DOI 10.2337-diabetes.51.10.3014; Bacha F, 2010, DIABETES CARE, V33, P2225, DOI 10.2337-dc10-0004; Bacha F, 2008, J PEDIATR, V152, P618, DOI 10.1016-j.jpeds.2007.11.044; Bacha F, 2004, DIABETES CARE, V27, P547, DOI 10.2337-diacare.27.2.547; Bacha F, 2009, DIABETES CARE, V32, P100, DOI 10.2337-dc08-1030; Burns SF, 2009, DIABETES CARE, V32, P2087, DOI 10.2337-dc09-0380; Buse JB, 2010, DIABETES CARE, V33, pe175; Buse John B, 2010, Diabetes Care, V33, pe175, DOI 10.2337-dc10-1720; Cali AMG, 2009, DIABETES CARE, V32, P456, DOI 10.2337-dc08-1274; Cnop M, 2007, DIABETES CARE, V30, P677, DOI 10.2337-dc06-1834; D'Adamo E, 2011, DIABETES CARE, V34, pS161, DOI 10.2337-dc11-s212; Fonseca V, 2009, DIABETES CARE, V32, P1344, DOI 10.2337-dc09-9034; George L, 2011, J CLIN ENDOCR METAB, V96, P2136, DOI 10.1210-jc.2010-2813; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016-S0140-6736(11)60472-8; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337-dc06-2003; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337-dc09-9033; Lee JM, 2011, J PEDIATR-US, V158, P947, DOI 10.1016-j.jpeds.2010.11.026; Lee JM, 2011, J PEDIAT, V158, pe1; Lee JM, 2011, DIABETES CARE, V34, P2597, DOI 10.2337-dc11-0827; Lee S, 2010, J CLIN ENDOCR METAB, V95, P2426, DOI 10.1210-jc.2009-2175; Libman IM, 2008, J CLIN ENDOCR METAB, V93, P4231, DOI 10.1210-jc.2008-0801; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337-diabetes.54.1.166; Malkani S, 2011, AM J MED, V124, P395, DOI 10.1016-j.amjmed.2010.11.025; Misra A, 2011, LANCET, V378, P104, DOI 10.1016-S0140-6736(11)60789-7; Nowicka P, 2011, DIABETES CARE, V34, P1306, DOI 10.2337-dc10-1984; Olson DE, 2010, DIABETES CARE, V33, P2184, DOI 10.2337-dc10-0433; Rosner B, 1998, J PEDIATR, V132, P211, DOI 10.1016-S0022-3476(98)70434-2; Selvin E, 2011, DIABETES CARE, V34, P84, DOI 10.2337-dc10-1235; Sjaarda LG, 2012, J PEDIATR-US, V161, P51, DOI 10.1016-j.jpeds.2011.12.050; Tanner J.M., 1969, ENDOCRINE GENETIC DI, P19; Tfayli H, 2009, DIABETES, V58, P738, DOI 10.2337-db08-1372; Tfayli H, 2010, DIABETES CARE, V33, P632, DOI 10.2337-dc09-0305; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337-dc08-1478
dc.description.citedCount 9
dc.description.citedTotWOSCount 12
dc.description.citedWOSCount 11
dc.format.extentCount 5
dc.identifier.articleNo
dc.identifier.coden DICAD
dc.identifier.pubmedID 22912428
dc.identifier.scopusID 84869791844
dc.identifier.url
dc.publisher.address 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr Diabetes Care
dc.relation.ispartOfIssue 12
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle Diabetes Care
dc.relation.ispartofPubTitleAbbr Diabetes Care
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 35
dc.source.ID WOS:000311426000041
dc.type.publication Journal
dc.subject.otherAuthKeyword
dc.subject.otherChemCAS glucose, 50-99-7, 84778-64-3
dc.subject.otherChemCAS hemoglobin A1c, 62572-11-6
dc.subject.otherChemCAS insulin, 9004-10-8
dc.subject.otherChemCAS Blood Glucose
dc.subject.otherChemCAS Hemoglobin A, Glycosylated
dc.subject.otherIndex glucose
dc.subject.otherIndex hemoglobin A1c
dc.subject.otherIndex insulin
dc.subject.otherIndex adolescent
dc.subject.otherIndex adult
dc.subject.otherIndex article
dc.subject.otherIndex child
dc.subject.otherIndex controlled study
dc.subject.otherIndex dysglycemia
dc.subject.otherIndex female
dc.subject.otherIndex glucose clamp technique
dc.subject.otherIndex human
dc.subject.otherIndex impaired glucose tolerance
dc.subject.otherIndex insulin sensitivity
dc.subject.otherIndex major clinical study
dc.subject.otherIndex male
dc.subject.otherIndex non insulin dependent diabetes mellitus
dc.subject.otherIndex obesity
dc.subject.otherIndex oral glucose tolerance test
dc.subject.otherIndex pancreas islet beta cell
dc.subject.otherIndex school child
dc.subject.otherIndex Adolescent
dc.subject.otherIndex Adult
dc.subject.otherIndex Blood Glucose
dc.subject.otherIndex Child
dc.subject.otherIndex Female
dc.subject.otherIndex Glucose Clamp Technique
dc.subject.otherIndex Hemoglobin A, Glycosylated
dc.subject.otherIndex Humans
dc.subject.otherIndex Insulin Resistance
dc.subject.otherIndex Insulin-Secreting Cells
dc.subject.otherIndex Male
dc.subject.otherIndex Obesity
dc.subject.otherIndex Overweight
dc.subject.otherIndex Young Adult
dc.subject.otherKeywordPlus IMPAIRED GLUCOSE-TOLERANCE
dc.subject.otherKeywordPlus ORAL DISPOSITION INDEX
dc.subject.otherKeywordPlus OBESE YOUTH
dc.subject.otherKeywordPlus SECRETION
dc.subject.otherKeywordPlus CHILDREN
dc.subject.otherKeywordPlus A1C
dc.subject.otherKeywordPlus HEMOGLOBIN
dc.subject.otherKeywordPlus SPECTRUM
dc.subject.otherWOS Endocrinology and Metabolism


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account